Insights From Survival Analyses During 12 Years of Anti–Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
From MaRDI portal
Publication:132249
DOI10.1001/JAMAOPHTHALMOL.2020.5044WikidataQ102203995 ScholiaQ102203995MaRDI QIDQ132249
Gabriella Moraes, Ernest Lim, Tiarnan D. Keenan, Praveen J. Patel, Dawn A. Sim, Josef Huemer, Livia Faes, Siegfried K. Wagner, Konstantinos Balaskas, Christoph Kern, Catey Bunce, Pearse A. Keane, Irene Stratton, Dun Jack Fu
Publication date: 1 January 2021
Published in: JAMA Ophthalmology (Search for Journal in Brave)
Related Items (1)
This page was built for publication: Insights From Survival Analyses During 12 Years of Anti–Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
